<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 19:04:21 -0700</creation_date>
  <update_date>2013-01-15 19:04:21 -0700</update_date>
  <accession>HMDBP02316</accession>
  <secondary_accessions>
    <accession>7801</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>ECP</synonym>
    <synonym>RNase 3</synonym>
    <synonym>Ribonuclease 3</synonym>
  </synonyms>
  <gene_name>RNASE3</gene_name>
  <general_function/>
  <specific_function>Cytotoxin and helminthotoxin with low-efficiency ribonuclease activity. Possesses a wide variety of biological activities. Exhibits antibacterial activity</specific_function>
  <pathways>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB15481</accession>
      <name>Pranlukast</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00094</accession>
      <name>Citric acid</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, acting on ester bonds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>nuclease activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>endonuclease activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>endoribonuclease activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>endoribonuclease activity, producing 3'-phosphomonoesters</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>pancreatic ribonuclease activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>nucleic acid binding</description>
      <go_id/>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Secreted</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>Chromosome:14</chromosome_location>
    <locus>14q24-q31</locus>
    <gene_sequence>&gt;483 bp
ATGGTTCCAAAACTGTTCACTTCCCAAATTTGTCTGCTTCTTCTGTTGGGGCTTATGGGT
GTGGAGGGCTCACTCCATGCCAGACCCCCACAGTTTACGAGGGCTCAGTGGTTTGCCATC
CAGCACATCAGTCTGAACCCCCCTCGATGCACCATTGCAATGCGGGCAATTAACAATTAT
CGATGGCGTTGCAAAAACCAAAATACTTTTCTTCGTACAACTTTTGCTAATGTAGTTAAT
GTTTGTGGTAACCAAAGTATACGCTGCCCTCATAACAGAACTCTCAACAATTGTCATCGG
AGTAGATTCCGGGTGCCTTTACTCCACTGTGACCTCATAAATCCAGGTGCACAGAATATT
TCAAACTGCAGGTATGCAGACAGACCAGGAAGGAGGTTCTATGTAGTTGCATGTGACAAC
AGAGATCCACGGGATTCTCCACGGTATCCTGTGGTTCCAGTTCACCTGGATACCACCATC
TAA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>160</residue_number>
    <molecular_weight>18386.0</molecular_weight>
    <theoretical_pi>10.33</theoretical_pi>
    <pfams>
      <pfam>
        <name>RnaseA</name>
        <pfam_id>PF00074</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
      <region>1-27</region>
    </signal_regions>
    <protein_sequence>&gt;Eosinophil cationic protein precursor
MVPKLFTSQICLLLLLGLMGVEGSLHARPPQFTRAQWFAIQHISLNPPRCTIAMRAINNY
RWRCKNQNTFLRTTFANVVNVCGNQSIRCPHNRTLNNCHRSRFRVPLLHCDLINPGAQNI
SNCTYADRPGRRFYVVACDNRDPRDSPRYPVVPVHLDTTI</protein_sequence>
  </protein_properties>
  <genbank_protein_id>31077</genbank_protein_id>
  <uniprot_id>P12724</uniprot_id>
  <uniprot_name>ECP_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1DYT</pdb_id>
  </pdb_ids>
  <genbank_gene_id>X15161</genbank_gene_id>
  <genecard_id>RNASE3</genecard_id>
  <geneatlas_id>RNASE3</geneatlas_id>
  <hgnc_id>HGNC:10046</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Rosenberg HF, Ackerman SJ, Tenen DG: Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med. 1989 Jul 1;170(1):163-76.</reference_text>
      <pubmed_id>2473157</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hamann KJ, Ten RM, Loegering DA, Jenkins RB, Heise MT, Schad CR, Pease LR, Gleich GJ, Barker RL: Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics. 1990 Aug;7(4):535-46.</reference_text>
      <pubmed_id>2387583</pubmed_id>
    </reference>
    <reference>
      <reference_text>Barker RL, Loegering DA, Ten RM, Hamann KJ, Pease LR, Gleich GJ: Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. J Immunol. 1989 Aug 1;143(3):952-5.</reference_text>
      <pubmed_id>2745977</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhang J, Rosenberg HF: Sequence variation at two eosinophil-associated ribonuclease loci in humans. Genetics. 2000 Dec;156(4):1949-58.</reference_text>
      <pubmed_id>11102386</pubmed_id>
    </reference>
    <reference>
      <reference_text>Heilig R, Eckenberg R, Petit JL, Fonknechten N, Da Silva C, Cattolico L, Levy M, Barbe V, de Berardinis V, Ureta-Vidal A, Pelletier E, Vico V, Anthouard V, Rowen L, Madan A, Qin S, Sun H, Du H, Pepin K, Artiguenave F, Robert C, Cruaud C, Bruls T, Jaillon O, Friedlander L, Samson G, Brottier P, Cure S, Segurens B, Aniere F, Samain S, Crespeau H, Abbasi N, Aiach N, Boscus D, Dickhoff R, Dors M, Dubois I, Friedman C, Gouyvenoux M, James R, Madan A, Mairey-Estrada B, Mangenot S, Martins N, Menard M, Oztas S, Ratcliffe A, Shaffer T, Trask B, Vacherie B, Bellemere C, Belser C, Besnard-Gonnet M, Bartol-Mavel D, Boutard M, Briez-Silla S, Combette S, Dufosse-Laurent V, Ferron C, Lechaplais C, Louesse C, Muselet D, Magdelenat G, Pateau E, Petit E, Sirvain-Trukniewicz P, Trybou A, Vega-Czarny N, Bataille E, Bluet E, Bordelais I, Dubois M, Dumont C, Guerin T, Haffray S, Hammadi R, Muanga J, Pellouin V, Robert D, Wunderle E, Gauguet G, Roy A, Sainte-Marthe L, Verdier J, Verdier-Discala C, Hillier L, Fulton L, McPherson J, Matsuda F, Wilson R, Scarpelli C, Gyapay G, Wincker P, Saurin W, Quetier F, Waterston R, Hood L, Weissenbach J: The DNA sequence and analysis of human chromosome 14.  Nature. 2003 Feb 6;421(6923):601-7. Epub 2003 Jan 1.</reference_text>
      <pubmed_id>12508121</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ: Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A. 1986 May;83(10):3146-50.</reference_text>
      <pubmed_id>3458170</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gabay JE, Scott RW, Campanelli D, Griffith J, Wilde C, Marra MN, Seeger M, Nathan CF: Antibiotic proteins of human polymorphonuclear leukocytes.  Proc Natl Acad Sci U S A. 1989 Jul;86(14):5610-4.</reference_text>
      <pubmed_id>2501794</pubmed_id>
    </reference>
    <reference>
      <reference_text>Boix E, Leonidas DD, Nikolovski Z, Nogues MV, Cuchillo CM, Acharya KR: Crystal structure of eosinophil cationic protein at 2.4 A resolution.  Biochemistry. 1999 Dec 21;38(51):16794-801.</reference_text>
      <pubmed_id>10606511</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mallorqui-Fernandez G, Pous J, Peracaula R, Aymami J, Maeda T, Tada H, Yamada H, Seno M, de Llorens R, Gomis-Ruth FX, Coll M: Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. J Mol Biol. 2000 Jul 28;300(5):1297-307.</reference_text>
      <pubmed_id>10903870</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mohan CG, Boix E, Evans HR, Nikolovski Z, Nogues MV, Cuchillo CM, Acharya KR: The crystal structure of eosinophil cationic protein in complex with 2',5'-ADP at 2.0 A resolution reveals the details of the ribonucleolytic active site. Biochemistry. 2002 Oct 8;41(40):12100-6.</reference_text>
      <pubmed_id>12356310</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Horiguchi T, Tachikawa S, Kasahara J, Doi M, Shiga M: Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma. Arzneimittelforschung. 1999 Jan;49(1):35-7.</reference_text>
        <pubmed_id>10028377</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Ishioka S, Hozawa S, Haruta Y, Hiyama K, Maeda A, Yamakido M: Pranlukast, a cysteinyl leukotriene antagonist, reduces serum eosinophil cationic protein levels in patients with asthma. Hiroshima J Med Sci. 1999 Dec;48(4):105-10.</reference_text>
        <pubmed_id>10804983</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Obase Y, Shimoda T, Tomari S, Mitsuta K, Fukushima C, Kawano T, Matsuse H, Kohno S: Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients. Ann Allergy Asthma Immunol. 2001 Jul;87(1):74-9.</reference_text>
        <pubmed_id>11476469</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pranlukast</name>
        <accession>HMDB15481</accession>
      </metabolite>
      <reference>
        <reference_text>Kanazawa H, Yoshikawa T, Hirata K, Yoshikawa J: Effects of pranlukast administration on vascular endothelial growth factor levels in asthmatic patients. Chest. 2004 May;125(5):1700-5.</reference_text>
        <pubmed_id>15136379</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Citric acid</name>
        <accession>HMDB00094</accession>
      </metabolite>
      <reference>
        <reference_text>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there?  Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</reference_text>
        <pubmed_id>17139284</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Citric acid</name>
        <accession>HMDB00094</accession>
      </metabolite>
      <reference>
        <reference_text>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets.  Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</reference_text>
        <pubmed_id>17016423</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
